511509 Stock Today

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>VB</div>
VIVO BIO is trading at 27.10 as of the 7th of July 2020, which is 2.26 percent increase since the beginning of the trading day. The stock's open price was 26.5. Equity ratings for VIVO BIO TECH are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 8th of April 2020 and ending today, the 7th of July 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores

VIVO BIO Profile

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India. VIVO BIO operates under Biotechnology classification in India and is traded on Bombay Stock Exchange. It employs 183 people. more on VIVO BIO
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of VIVO BIO available fundamental, technical, and predictive indicators. Current horizon is 30 days (very short) - details
Not RatedOvervalued
VIVO BIO TECH (511509) is traded on Bombay Stock Exchange in India and employs 183 people. The company currently falls under 'Small-Cap' category with current market capitalization of 266.49 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VIVO BIO's market, we take the total number of its shares issued and multiply it by VIVO BIO's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. VIVO BIO TECH operates under Healthcare sector and is part of Biotechnology industry. The entity has 9.35 M outstanding shares. The company has accumulated about 28.22 M in cash with (56.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.02.
Check VIVO BIO Probability Of Bankruptcy

511509 Stock Price Odds Analysis

Odds Down 27.1HorizonTargetOdds Up 27.1
34.34%30 days
Based on a normal probability distribution, the odds of VIVO BIO to move above the current price in 30 days from now is about 65.54 (This VIVO BIO TECH probability density function shows the probability of VIVO BIO Stock to fall within a particular range of prices over 30 days) .

VIVO BIO TECH Risk Profiles

511509 Stock Against Markets

View Currently Related Equities

Please continue to Trending Equities. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page